As several inflammatory mediators, such as NF-κB, NLRP3, and mitogen-activated protein kinase (MAPK) signaling pathways, were all activated in CKD and could represent a potential target for STS [37,38], studying these mechanisms might also be an interesting alternative target to explore. This evidence concerns the gene NFKB1 and chronic kidney disease.